ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GMX Reliance Gen.

0.55
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Reliance Gen. LSE:GMX London Ordinary Share GB00B1MM9925 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.55 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Reliance Genemedix Share Discussion Threads

Showing 601 to 615 of 625 messages
Chat Pages: 25  24  23  22  21  20  19  18  17  16  15  14  Older
DateSubjectAuthorDiscuss
03/2/2010
20:03
whats happened here?normally there would be rampers all over a rise like this.
seems to of gone unnoticed....

olly2
03/2/2010
14:35
vertical, perhaps due to the warrant conversion at 12.5p, although that gives tha majority shareholder 79%.....

saffy..

safman
10/4/2008
10:19
Anyone know the latest on this?
undertaker
21/6/2007
16:10
40,000 shares bought or sold today.
barbra2
01/6/2007
10:12
has this really got 9 mill cash yet mcap below that.
powwow
07/2/2007
16:37
Don't know enough about the company wiganer. You shorting it?
Good Wigan URL

:)

volsung
07/2/2007
16:32
Looks a cracking short for anyone who goes in for that kind of thing vols.

Compare the current price with the placing price.

wiganer
07/2/2007
16:30
Dis has did well good today.
volsung
25/7/2006
12:31
Why is this company cap'd @£14million, is it april 1st, on my calc the share price should be 1/2p...any thoughts?
jotoha1
17/1/2006
19:50
Full time results Friday. share price will add a bit I believe but a safe holding to offset CGT.
eriktherock
23/11/2005
19:50
I only hold to offset CGT. lol. 30p soon
eriktherock
11/11/2005
19:18
Post removed by ADVFN
Abuse team
13/10/2005
11:09
ENCOURAGING STUFF!

RNS Number:6088S
GeneMedix PLC
13 October 2005

FOR IMMEDIATE RELEASE 13 October 2005

GENEMEDIX PLC
Sale of Chinese Facility, Convertible Loan Funding

GeneMedix plc ("GeneMedix" or "the Company"), the UK biopharmaceutical company
with operations in Europe and Asia and with joint London and Singapore Stock
Exchange listings, announces that, as part of its recently announced
restructuring, it has signed a binding letter of intent for the sale of its
Chinese facility and has entered into a related party transaction to bring in
additional financing to the business.

The £500,000 financing will contribute to the Company's immediate funding
requirements, and the sale of the Chinese facility, after payment of all debt,
will provide approximately £1.6 million in early 2006. If the Company is to
continue to pursue it EPO programme at its current rate, additional financing
will be required over the coming months. The Board of Directors plans to access
this additional funding from the restructuring process.

The Chinese facility has not been part of the Company's core activities for some
time and the funding of the sale will occur upon receipt of Chinese government
approval.

In the financing, GeneMedix placed a convertible loan of £500,000 with its
founder and Chairman, Dr Kim Tan. These loan notes are convertible into between
11.8 and 13.1 million shares of the Company's shares when the Company completes
its next share offering. To facilitate the financing of this convertible loan, a
trust holding certain of Dr Kim Tan's shares in GeneMedix disposed of 18,567,397
GeneMedix shares at a price of 2.8p in a private placing with a non-connected
party.

Julian Attfield, Acting Chief Executive Officer of GeneMedix commented:

"We are delighted that our restructuring efforts have begun in such a positive
manner. The cash proceeds from the sale of the Chinese facility will be welcome
in meeting our cash requirements in early 2006. We are also grateful to Dr Tan
for his continued financial support for the Company which allows us more time to
advance the current financing and corporate activities whilst continuing at full
speed with our development activities."

Notification of these transactions has been made today in accordance with
Disclosure Rule 3.1.4R(1)(a) of the Disclosure Rules sourcebook. Following this
transaction, Dr Kim Tan has a total actual beneficial interest in 128,786,159
ordinary shares, representing 34.7% of the enlarged share capital of the
Company, but this will increase to a maximum of 141,858,054 ordinary shares
representing 36.9% of the enlarged share capital of the Company, once the loan
notes have been converted. Mr J Attfield, Acting CEO of GeneMedix, is the duly
authorised officer of the Company responsible for making the notification.

ENQUIRIES:

eriktherock
06/10/2005
11:05
Just read it. Don't see a problem do you?
eriktherock
06/10/2005
09:13
How about the announcement now ?
polleyn
Chat Pages: 25  24  23  22  21  20  19  18  17  16  15  14  Older

Your Recent History

Delayed Upgrade Clock